This Metric Says You Are Smart to Sell Lexicon Pharmaceuticals, Inc. (LXRX)

Is Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) the right investment to pursue these days? The smart money is taking a pessimistic view. The number of long hedge fund bets dropped by 3 lately.

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

In today’s marketplace, there are tons of metrics shareholders can use to analyze stocks. A pair of the most under-the-radar are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the elite investment managers can trounce their index-focused peers by a very impressive amount (see just how much).

Just as important, positive insider trading sentiment is a second way to parse down the stock market universe. As the old adage goes: there are a number of incentives for an insider to cut shares of his or her company, but just one, very clear reason why they would behave bullishly. Many empirical studies have demonstrated the useful potential of this tactic if “monkeys” know where to look (learn more here).

With these “truths” under our belt, we’re going to take a glance at the latest action surrounding Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX).

How have hedgies been trading Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)?

At the end of the fourth quarter, a total of 7 of the hedge funds we track were long in this stock, a change of -30% from one quarter earlier. With hedge funds’ capital changing hands, there exists an “upper tier” of notable hedge fund managers who were increasing their stakes substantially.

Of the funds we track, Chuck Royce’s Royce & Associates had the most valuable position in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), worth close to $9.8 million, accounting for less than 0.1%% of its total 13F portfolio. Sitting at the No. 2 spot is Perceptive Advisors, managed by Joseph Edelman, which held a $5.3 million position; the fund has 0.9% of its 13F portfolio invested in the stock. Some other peers that hold long positions include Steven Cohen’s SAC Capital Advisors, SAC Subsidiary’s Sigma Capital Management and D. E. Shaw’s D E Shaw.

Since Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) has witnessed bearish sentiment from the entirety of the hedge funds we track, it’s easy to see that there was a specific group of hedge funds that elected to cut their full holdings last quarter. At the top of the heap, Israel Englander’s Millennium Management dropped the largest investment of all the hedgies we watch, comprising close to $0.5 million in stock.. Wayne Holman’s fund, Ridgeback Capital Management, also sold off its stock, about $0.2 million worth. These bearish behaviors are important to note, as total hedge fund interest was cut by 3 funds last quarter.

How are insiders trading Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)?

Insider buying is best served when the company we’re looking at has seen transactions within the past six months. Over the last 180-day time frame, Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) has seen 2 unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX). These stocks are Nektar Therapeutics (NASDAQ:NKTR), PDL BioPharma Inc. (NASDAQ:PDLI), Sarepta Therapeutics Inc (NASDAQ:SRPT), VIVUS, Inc. (NASDAQ:VVUS), and Santarus, Inc. (NASDAQ:SNTS). This group of stocks are in the biotechnology industry and their market caps are similar to LXRX’s market cap.

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Nektar Therapeutics (NASDAQ:NKTR) 9 0 0
PDL BioPharma Inc. (NASDAQ:PDLI) 14 0 0
Sarepta Therapeutics Inc (NASDAQ:SRPT) 16 0 1
VIVUS, Inc. (NASDAQ:VVUS) 19 0 0
Santarus, Inc. (NASDAQ:SNTS) 16 1 12

With the returns demonstrated by our research, everyday investors must always monitor hedge fund and insider trading activity, and Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is an important part of this process.

Click here to learn why you should track hedge funds

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!